The cardiovascular actions of protease-activated receptors

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 2-11

  Steinberg, Susan F ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 200261; G PROTEIN COUPLED RECEPTOR; N 3 AMINO 1 [[[(PHENYLMETHYL)AMINO]CARBONYL]PROPYL] ALPHA [[[[[1 (2,6 DICHLOROPHENYL)METHYL] 3 [1 PYRROLIDINYLMETHYL] 1 H INDOL 6 YL]AMINO]CARBONYL]AMINO] 3,4 DIFLUOROBENZENEPROPANAMIDE; PEPTIDE HYDROLASE INHIBITOR; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RWJ 56110; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; EMBRYO; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; MORPHOLOGICAL ADAPTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; SHORT SURVEY; VASCULARIZATION; VASODILATATION;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR PHYSIOLOGIC PROCESSES; HEART; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, THROMBIN; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 11244297746     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.003103     Document Type: Short Survey

References (41)

1. Albitz R, Droogmans G, Nilius B, and Casteels R (1992) Thrombin stimulates L-type calcium channels of guinea pig cardiomyocytes in cell-attached patches but not after intracellular dialysis. Cell Calcium 13:203-210.
2. Blackhart BD, Ruslim-Litrus L, Lu CC, Alves VL, Teng W, Scarborough RM, Reynolds EE, and Oksenberg D (2000) Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. Mol Pharmacol 58:1178-1187.
3. Chien WW, Mohabir R, and Clusin WT (1990) Effect of thrombin on calcium homeostasis in chick embryonic heart cells. J Clin Investig 85:1436-1443.
4. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, Cruchley A, Kapas S, Howells GL, and Cirino G (1999) Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99:2590-2597.
5. Compton SJ, Cairns JA, Palmer KJ, Al Ani B, Hollenberg MD, and Walls AF (2000) A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists. J Biol Chem 275:39207-39212.
6. Compton SJ, Sandhu S, Wijesuriya SJ, and Hollenberg MD (2002) Glycosylation of human proteinase-activated receptor-2 (HPAR2): role in cell surface expression and signalling. Biochem J 368:495-505.
7. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature (Lond) 407:258-264.
8. Griffin CT, Srinivasan Y, Zheng YW, Huang W, and Coughlin SR (2001) A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (Wash DC) 293:1666-1670.
9. Iacoviello L, Kolpakov V, Salvatore L, Amore C, Pintucci G, de Gaetano G, and Donati MB (1995) Human endothelial cell damage by neutrophil-derived cathepsin G. Role of cytoskeleton rearrangement and matrix-bound plasminogen activator inhihitor-1. Arterioscler Thromb Vasc Biol 15:2037-2046.
10. Jacobsen AN, Du XJ, Lambert KA, Dart AM, and Woodcock EA (1996) Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation 93:23-26.
11. Jacques SL and Kuliopulos A (2003) Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. Biochem J 376:733-740.
12. Jiang T, Danilo P, and Steinberg SF (1998) The thrombin receptor elevates intracellular calcium in adult rat ventricular myocytes. J Mol Cell Cardiol 30:2193-2199.
13. Jiang T, Kuznetsov V, Pak E, Zhang HL, Robinson RB, and Steinberg SF (1996) Thrombin receptor actions in neonatal rat ventricular myocytes. Circ Res 78:553-563.
14. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, Griffin C, and Coughlin SR (2003) Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102:3224-3231.
15. Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M, Sekiguchi F, Kubo S, Kuroda R, Iwaki M, et al. (2004) Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 309:1098-1107.
16. Ludeman MJ, Zheng YW, Ishii K, and Coughlin SR (2004) Regulated shedding of PARI N-terminal exodomain from endothelial cells. J Biol Chem 279:18592-18599.
17. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, and Plevin R (2001) Proteinase-activated receptors. Pharmacol Rev 53:245-282.
18. Major CD, Santulli RJ, Derian CK, and Andrade-Gordon P (2003) Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol 23:931-939.
19. McLean PG, Aston D, Sarkar D, and Ahluwalia A (2002) Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors and C-fibers. Circ Res 90:465-472.
20. Milia AF, Salis MB, Stacca T, Pinna A, Madeddu P, Trevisani M, Geppetti P, and Emanueli C (2002) Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res 91:346-352.
21. Mirza H, Yatsula V, and Bahou WF (1996) The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: molecular characterization and evidence for functional coupling to the thrombin receptor. J Clin Investis 97:1705-1714.
22. Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C, and Brass LF (1995) Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 270:11168-11175.
23. Napoli C, Cicala C, Wallace JL, De Nigris F, Santagada V, Caliendo G, Franconi F, Ignarro LJ, and Cirino G (2000) Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci USA 97:3678-3683.
24. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, and Brass LF (2000) Thrombin responses in human endothelial cells, contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275:13502-13509.
25. Ossovskaya VS and Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579-621.
26. Patella V, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, and Marone G (1998) Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971-978.
27. Quinton TM, Kim S, Derian CK, Jin J, and Kunapuli SP (2004) Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem 279:18434-18439.
28. Renesto P, Si-Tahar M, Moniatte M, Balloy V, van Dorsselaer A, Pidard D, and Chignard M (1997) Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89:1944-1953.
29. Robin J, Kharbanda R, Mclean P, Campbell R, and Vallance P (2003) Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids. Circulation 107:954-959.
30. 2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains. Mol Pharmacol 63:1338-1348.
31. Sabri A, Alcott SG, Elouardighi H, Pak E, Derian C, Andrade-Gordon P, Kinnally K, and Steinberg SF (2003a) Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J Biol Chem 278:23944-23954.
32. Sabri A, Guo J, Elouardighi H, Darrow AL, Andrade-Gordon P, and Steinberg SF (2003b) Mechanisms of protease-activated receptor-4 actions in cardiomyocytes: role of Src tyrosine kinase. J Biol Chem 278:11714-11720.
33. Sabri A, Muske G, Zhang H, Pak E, Darrow A, Andrade-Gordon P, and Steinberg SF (2000) Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res 88:1054-1061.
34. Sabri A, Short J, Guo J, and Steinberg SF (2002) Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91:532-539.
35. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, and Coughlin SR (2000) Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275:6819-6823.
36. Steinberg SF, Robinson RB, Lieberman HB, Stern DM, and Rosen MR (1991) Thrombin modulates phosphoinositide metabolism, cytosolic calcium and impulse initiation in the heart. Circ Res 68:1216-1229.
37. Vergnolle N (2000) Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 14:257-266.
38. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, et al. (2001) Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 7:821-826.
39. 3 and cardiac dysfunction. Cardiovasc Res 40:251-256.
40. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res 79:705-715.
41. Zhang HC, White KB, McComsey DF, Addo MF, Andrade-Gordon P, Derian CK, Oksenberg D, and Maryanoff BE (2003) High-affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus. Bioorg Med Chem Lett 13:2199-2203.